

Avacta Therapeutics Information
Contact top employees from
Avacta Therapeutics
Summary
Avacta Therapeutics is a public company that has been in the industry for 22 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the CEO is occupied by Alastair Smith. Its headquarters is located at Wetherby, England, GB. The number of employees ranges from 100 to 250. The annual revenue of Avacta Therapeutics varies between 100K and 5.0M. Total funding of the company - $24.2M. To connect with Avacta Therapeutics employee register on SignalHire.
Organization Website | avacta.com |
Social Links | |
Phone Number | 0844-414-0452 |
Industries | |
Headquarters Location | Scale Space, White City, London, GB |
Employees Size | 100-200 employees |
Specialties | Custom antibody alternative, Antibody alternatives, Afinnity reagents |
SIC Code | 2834 |
Founded | 2012 |
Estimated Annual Revenue | $100K - 5.0M |
Operating Status | Independent Company |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Avacta Therapeutics shows a diverse range of experience levels:
5% have been with the company for less than 1 year8% for 1–2 years15% for 3–4 years20% for 5–7 years30% for 8–10 years23% have over 11 years of service at Avacta TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Avacta Therapeutics
Karen Campbell
Vice President Clinical Operations
Christina Coughlin
Chief Executive Officer
Brian Hahn
Chief Financial Officer
David Liebowitz
Chief Medical Officer
Similar Companies
FAQ
Avacta Therapeutics operates in the Biotech industries. More details can be found on the official website: avacta.com.
The headquarters of Avacta Therapeutics are located in London, United Kingdom.
The current CEO of Avacta Therapeutics is Alastair Smith
You can contact Avacta Therapeutics by phone at 0844-414-0452.
Avacta Therapeutics currently employs 100-200 people.
Avacta Therapeutics's revenue is approximately 4.9M.




